Thank you, Madam Chair.
To the CEO of Providence, it's my understanding that there are concerns about the efficacy against variants of some of the adenovirus-based vaccines, such as Novavax and AstraZeneca. Is that your understanding?
On February 16th, 2021. See this statement in context.